Skip to main content
. 2021 Dec 22;23(1):100. doi: 10.3390/ijms23010100

Figure 2.

Figure 2

Main effects of MEL on diabetic neuropathy in experimental studies. Arrows point down: decrease; arrows point up: increase. *, TAC: total antioxidant capacity; GSH: glutathione-S-transferase; SOD: superoxide dismutase; CAT: catalase; ROS: reactive oxygen species; MDA: malondialdehyde; TNF-α: Tumor Necrosis Factor alpha; iNOS: inducible nitric oxide synthase; VEGF: vascular endothelial growth factor; NF-κB: nuclear factor-kappa B; IL-6: interleukin 6; IL-4: interleukin 4; IL-1β: interleukin 1 beta; GFAP: glial fibrillary acidic protein; MNCV: motor nerve conduction velocity; NBF: nerve blood flow. The respective references can be found subscribed in parentheses.